Dan Hartman
Impact in
- Family Practice top 10%
Papers in
-
- Pregnancy and Medication Impact 2
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 2
- Co-authors
- Vincent I. Ahonkhai (1 shared paper)Jeffrey Aronson (1 shared paper)Alasdair M. Breckenridge (1 shared paper)Terrence F. Blaschke (1 shared paper)Carl C. Peck (1 shared paper)Murray Lumpkin (1 shared paper)Bernard Vrijens (1 shared paper)Jane A. May (2 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (3 papers)Platelets (2 papers)PLoS ONE (1 paper)PLoS Medicine (1 paper)Clinical and Translational Science (1 paper)
- Partner nations
- United StatesUnited KingdomRwanda
In The Last Decade
Dan Hartman
18 papers receiving 316 citations
Peers
Comparison fields: 5 of 79
- Family Practice 14
- Internal Medicine 17
- Pharmacology 68
- Hepatology 26
- Biochemistry 20
Countries citing papers authored by Dan Hartman
This map shows the geographic impact of Dan Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Hartman more than expected).
Fields of papers citing papers by Dan Hartman
This network shows the impact of papers produced by Dan Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Hartman. The network helps show where Dan Hartman may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Hartman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 68 | |
| 2 | 2008 | 60 | |
| 3 | 2016 | 55 | |
| 4 | 1994 | 35 | |
| 5 | 2020 | 28 | |
| 6 | 2012 | 28 | |
| 7 | 2020 | 9 | |
| 8 | 2020 | 7 | |
| 9 | 1986 | 7 | |
| 10 | 2022 | 7 | |
| 11 | 2012 | 6 | |
| 12 | 2019 | 6 | |
| 13 | 2020 | 4 | |
| 14 | 2019 | 4 | |
| 15 | 2019 | 4 | |
| 16 | 2024 | 4 | |
| 17 | 2019 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2022 | 0 | |
| 20 | 2026 | 0 |
About Dan Hartman
Dan Hartman is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics, Infectious Diseases, Computational Theory and Mathematics and Pediatrics, Perinatology and Child Health, having authored 20 papers that have together received 334 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Computational Drug Discovery Methods (3 papers), HIV/AIDS drug development and treatment (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Inflammatory mediators and NSAID effects (2 papers), Pharmaceutical Economics and Policy (2 papers), Pharmaceutical studies and practices (2 papers) and Pregnancy and Medication Impact (2 papers). The work is most often cited by research in Family Practice (14 citations), Internal Medicine (17 citations), Pharmacology (68 citations), Hepatology (26 citations) and Biochemistry (20 citations). Dan Hartman has collaborated with scholars based in United States, United Kingdom and Rwanda. Frequent co-authors include Vincent I. Ahonkhai, Jeffrey Aronson, Alasdair M. Breckenridge, Terrence F. Blaschke, Carl C. Peck, Murray Lumpkin, Bernard Vrijens, Jane A. May, Andrew J. Johnson and Stan Heptinstall. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Platelets, PLoS ONE, PLoS Medicine and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.